Artesunate exerts a direct effect on endothelial cell activation and NF-κB translocation in a mechanism independent of plasmodium killing

Malaria Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Souza, Mariana C ^a   Paixão, Flávio Henrique Marcolino ^a   Ferraris, Fausto K ^a   Ribeiro, Isabela ^b   Henriques, Maria Das Graças M O ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Drugs for Neglected Diseases Initiative   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEFLOQUINE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MALARIA; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ERYTHROCYTE ADHESIVENESS; EXPERIMENTAL INFECTION; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SINGLE DRUG DOSE; SPLEEN CELL; VASCULAR ENDOTHELIUM;

EID: 84873251784     PISSN: 20908075     EISSN: 20444362     Source Type: Journal    
DOI: 10.1155/2012/679090     Document Type: Article

References (43)

1. Woodrow C. J., Haynes R. K., Krishna S., Artemisinins. Postgraduate Medical Journal 2005 81 952 71 78 2-s2.0-14144252096 10.1136/pgmj.2004.028399 (Pubitemid 40282867)
2. Maude R. J., Woodrow C. J., White L. J., Artemisinin antimalarials: preserving the magic bullet Drug Development Research 2010 71 1 12 19 2-s2.0-76749157867 10.1002/ddr.20344
3. Efferth T., Dunstan H., Sauerbrey A., Miyachi H., Chitambar C. R., The anti-malarial artesunate is also active against cancer. International Journal of Oncology 2001 18 4 767 773 2-s2.0-0035315838
4. Kaptein S. J. F., Efferth T., Leis M., Rechter S., Auerochs S., Kalmer M., Bruggeman C. A., Vink C., Stamminger T., Marschall M., The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Antiviral Research 2006 69 2 60 69 2-s2.0-31444451671 10.1016/j.antiviral.2005. 10.003 (Pubitemid 43152041)
5. Mirshafiey A., Saadat F., Attar M., Di Paola R., Sedaghat R., Cuzzocrea S., Design of a new line in treatment of experimental rheumatoid arthritis by artesunate. Immunopharmacology and Immunotoxicology 2006 28 3 397 410 2-s2.0-33749026645 10.1080/08923970600927447 (Pubitemid 44451569)
6. Tawfik A. F., Bishop S. J., Ayalp A., El-Feraly F. S., Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice. International Journal of Immunopharmacology 1990 12 4 385 389 2-s2.0-0025358303 10.1016/0192-0561(90)90019-J (Pubitemid 20203629)
7. Veerasubramanian P., Gosi P., Limsomwong C., Walsh D. S., Artesunate and a major metabolite, dihydroartemisinin, diminish MITOGEN-induced lymphocyte proliferation and activation. Southeast Asian Journal of Tropical Medicine and Public Health 2006 37 5 838 847 2-s2.0-33751582721 (Pubitemid 44843982)
8. Wang J., Zhou H., Zheng J., Cheng J., Liu W., Ding G., Wang L., Luo P., Lu Y., Cao H., Yu S., Li B., Zhang L., The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Eschenchia coli challenge by decreasing proinflammatory cytokine release. Antimicrobial Agents and Chemotherapy 2006 50 7 2420 2427 2-s2.0-33745631534 10.1128/AAC.01066-05 (Pubitemid 43993181)
9. Xu H., He Y., Yang X., Liang L., Zhan Z., Ye Y., Yang X., Lian F., Sun L., Anti-malarial agent artesunate inhibits TNF- α -induced production of proinflammatory cytokines via inhibition of NF- κ B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology 2007 46 6 920 926 2-s2.0-34447324890 10.1093/rheumatology/kem014 (Pubitemid 47062496)
10. Li B., Li J., Pan X., Ding G., Cao H., Jiang W., Zheng J., Zhou H., Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF- α release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF- κ B activation. International Immunopharmacology 2010 10 3 344 350 2-s2.0-76849087245 10.1016/j.intimp.2009. 12.006
11. Cheng C., Ho W. E., Goh F. Y., Guan S. P., Kong L. R., Lai W. Q., Leung B. P., Wong W. S. F., Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway. PLoS ONE 2011 6 6 2-s2.0-79958273737 10.1371/journal.pone.0020932 e20932
12. van der Heyde H. C., Nolan J., Combes V., Gramaglia I., Grau G. E., A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends in Parasitology 2006 22 11 503 508 2-s2.0-33749266350 10.1016/j.pt.2006.09.002 (Pubitemid 44479847)
13. de Souza J. B., Hafalla J. C. R., Riley E. M., Couper K. N., Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 2010 137 5 755 772 2-s2.0-77953616680 10.1017/S0031182009991715
14. Fidock D. A., Rosenthal P. J., Croft S. L., Brun R., Nwaka S., Antimalarial drug discovery: efficacy models for compound screening. Nature Reviews Drug Discovery 2004 3 6 509 520 2-s2.0-3042550882 (Pubitemid 38807533)
15. Clemmer L., Martins Y. C., Zanini G. M., Frangos J. A., Carvalho L. J. M., Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain. Antimicrobial Agents and Chemotherapy 2011 55 4 1383 1390 2-s2.0-79953185013 10.1128/AAC.01277-10
16. Bauer P. R., van der Heyde H. C., Sun G., Specian R. D., Granger D. N., Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 2002 9 6 463 470 2-s2.0-0040078401 10.1038/sj.mn.7800159 (Pubitemid 135684856)
17. Desruisseaux M. S., Machado F. S., Weiss L. M., Tanowitz H. B., Golightly L. M., Cerebral malaria: a vasculopathy. American Journal of Pathology 2010 176 3 1075 1078 2-s2.0-77749254599 10.2353/ajpath.2010.091090
18. Janse C. J., Waters A. P., Kos J., Lugt C. B., Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei -rodent model. International Journal for Parasitology 1994 24 4 589 594 2-s2.0-0028068979 10.1016/0020-7519(94)90150-3 (Pubitemid 24234513)
19. de Vries P. J., Dien T. K., Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996 52 6 818 836 2-s2.0-0029843392 (Pubitemid 26413293)
20. van der Heyde H. C., Bauer P., Sun G., Chang W. L., Yin L., Fuseler J., Granger D. N., Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique. Infection and Immunity 2001 69 5 3460 3465 2-s2.0-0035064172 10.1128/IAI.69.5.3460-3465.2001 (Pubitemid 32332251)
21. Pamplona A., Ferreira A., Balla J., Jeney V., Balla G., Epiphanio S., Chora A., Rodrigues C. D., Gregoire I. P., Cunha-Rodrigues M., Portugal S., Soares M. P., Mota M. M., Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nature Medicine 2007 13 6 703 710 2-s2.0-34250008488 10.1038/nm1586 (Pubitemid 46889755)
22. + T-cell-mediated Trypanosoma cruzi -elicited meningoencephalitis. Journal of Neuroimmunology 2003 142 1-2 17 30 2-s2.0-0346971400 10.1016/S0165-5728(03)00254-6 (Pubitemid 38368585)
23. Walther B. T., Ohman R., Roseman S., A quantitative assay for intercellular adhesion. Proceedings of the National Academy of Sciences of the United States of America 1973 70 5 1569 1573 2-s2.0-0015880238
24. de Assis M. C., Plotkowski M. C., Fierro I. M., Barja-Fidalgo C., de Freitas M. S., Expression of inducible nitric oxide synthase in human umbilical vein endothelial cells during primary culture. Nitric Oxide 2002 7 4 254 261 2-s2.0-0036435983 10.1016/S1089-8603(02)00123-4 (Pubitemid 35365670)
25. Viebig N. K., Wulbrand U., Förster R., Andrews K. T., Lanzer M., Knolle P. A., Direct activation of human endothelial cells by Plasmodium falciparum -infected erythrocytes. Infection and Immunity 2005 73 6 3271 3277 2-s2.0-19744372987 10.1128/IAI.73.6.3271-3277.2005 (Pubitemid 40745866)
26. Kamchonwongpaisan S., Meshnick S. R., The mode of action of the antimalarial artemisinin and its derivatives. General Pharmacology 1996 27 4 587 592 2-s2.0-0030176425 10.1016/0306-3623(95)02047-0 (Pubitemid 26233325)
27. Li W. D., Dong Y. J., Tu Y. Y., Lin Z. B., Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF- α and blocking the signaling pathway NF- κ B translocation. International Immunopharmacology 2006 6 8 1243 1250 2-s2.0-33744995205 10.1016/j.intimp.2006. 03.004 (Pubitemid 43868185)
28. Li B., Zhang R., Li J., Zhang L., Ding G., Luo P., He S., Dong Y., Jiang W., Lu Y., Cao H., Zheng J., Zhou H., Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF- κ B activation. International Immunopharmacology 2008 8 3 379 389 2-s2.0-39149123815 10.1016/j.intimp.2007.10.024
29. Baptista F. G., Pamplona A., Pena A. C., Mota M. M., Pied S., Vigário A. M., Accumulation of Plasmodium berghei -infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infection and Immunity 2010 78 9 4033 4039 2-s2.0-77956634056 10.1128/IAI.00079-10
30. Amante F. H., Haque A., Stanley A. C., Rivera F. D. L., Randall L. M., Wilson Y. A., Yeo G., Pieper C., Crabb B. S., de Koning-Ward T. F., Lundie R. J., Good M. F., Pinzon-Charry A., Pearson M. S., Duke M. G., McManus D. P., Loukas A., Hill G. R., Engwerda C. R., Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. Journal of Immunology 2010 185 6 3632 3642 2-s2.0-78649848029 10.4049/jimmunol.1000944
31. Cabrales P., Zanini G. M., Meays D., Frangos J. A., Carvalho L. J. M., Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. Journal of Infectious Diseases 2011 203 10 1454 1463 2-s2.0-79955026263 10.1093/infdis/jir058
32. Sarciron M. E., Saccharin C., Petavy A. F., Peyron F., Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii. American Journal of Tropical Medicine and Hygiene 2000 62 1 73 76 2-s2.0-0034030445 (Pubitemid 30180353)
33. Chen H. H., Zhou H. J., Wu G. D., Lou X. E., Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology 2004 71 1 1 9 2-s2.0-1642619557 10.1159/000076256 (Pubitemid 38410706)
34. Ohayon A., Golenser J., Sinay R., Tamir A., Altman A., Pollack Y., Isakov N., Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria. Infection and Immunity 2010 78 10 4195 4205 2-s2.0-77957746730 10.1128/IAI.00465-10
35. Favre N., Da Laperousaz C., Ryffel B., Weiss N. A., Imhof B. A., Rudin W., Lucas R., Piguet P. F., Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes and Infection 1999 1 12 961 968 2-s2.0-0032695542 10.1016/S1286-4579(99)80513-9
36. Joergensen L., Bengtsson D. C., Bengtsson A., Ronander E., Berger S. S., Turner L., Dalgaard M. B., Cham G. K. K., Victor M. E., Lavstsen T., Theander T. G., Arnot D. E., Jensen A. T. R., Surface co-expression of two different PfEMP1 antigens on single Plasmodium falciparum -infected erythrocytes facilitates binding to ICAM1 and PECAM1. PLoS Pathogens 2010 6 9 2-s2.0-78149348505 10.1371/journal.ppat.1001083 e01083
37. Fedosov D. A., Caswell B., Suresh S., Karniadakis G. E., Quantifying the biophysical characteristics of Plasmodium-falciparum-parasitized red blood cells in microcirculation. Proceedings of the National Academy of Sciences of the United States of America 2011 108 1 35 39 2-s2.0-78651087114 10.1073/pnas.1009492108
38. Semmrich M., Smith A., Feterowski C., Beer S., Engelhardt B., Busch D. H., Bartsch B., Laschinger M., Hogg N., Pfeffer K., Holzmann B., Importance of integrin LFA-1 deactivation for the generation of immune responses. Journal of Experimental Medicine 2005 201 12 1987 1998 2-s2.0-22344438374 10.1084/jem.20041850 (Pubitemid 41002934)
39. Tripathi A. K., Sullivan D. J., Stins M. F., Plasmodium falciparum -infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF- κ B. Infection and Immunity 2006 74 6 3262 3270 2-s2.0-33646947271 10.1128/IAI.01625-05 (Pubitemid 43794513)
40. Tripathi A. K., Sha W., Shulaev V., Stins M. F., Sullivan D. J. Jr., Plasmodium falciparum -infected erythrocytes induce NF- κ B regulated inflammatory pathways in human cerebral endothelium. Blood 2009 114 19 4243 4252 2-s2.0-77950530988 10.1182/blood-2009-06-226415
41. Aldieri E., Atragene D., Bergandi L., Riganti C., Costamagna C., Bosia A., Ghigo D., Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF- κ B activation. FEBS Letters 2003 552 2-3 141 144 2-s2.0-0141537877 10.1016/S0014-5793(03)00905-0 (Pubitemid 37186850)
42. Hehner S. P., Heinrich M., Bork P. M., Vogt M., Ratter F., Lehmann V., Schulze-Osthoff K., Dröge W., Schmitz M. L., Sesquiterpene lactones specifically inhibit activation of NF- κ B by preventing the degradation of I κ B- α and I κ B- β The Journal of Biological Chemistry 1998 273 3 1288 1297 2-s2.0-0031915368 10.1074/jbc.273.3.1288 (Pubitemid 28133643)
43. Ly G., Knorre A., Schmidt T. J., Pahl H. L., Merfort I., The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF- κ B by directly targeting p65. The Journal of Biological Chemistry 1998 273 50 33508 33516 2-s2.0-0001112989 10.1074/jbc.273.50.33508 (Pubitemid 29005734)